These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Drugs, games, and devices for enhancing cognition: implications for work and society. Brühl AB; Sahakian BJ Ann N Y Acad Sci; 2016 Apr; 1369(1):195-217. PubMed ID: 27043232 [TBL] [Abstract][Full Text] [Related]
11. How Realistic Are the Scientific Assumptions of the Neuroenhancement Debate? Assessing the Pharmacological Optimism and Neuroenhancement Prevalence Hypotheses. Schleim S; Quednow BB Front Pharmacol; 2018; 9():3. PubMed ID: 29403383 [TBL] [Abstract][Full Text] [Related]
12. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Cakic V J Med Ethics; 2009 Oct; 35(10):611-5. PubMed ID: 19793941 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects. Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Liechti ME; Borgwardt S Int J Neuropsychopharmacol; 2017 Sep; 20(9):712-720. PubMed ID: 28525569 [TBL] [Abstract][Full Text] [Related]
14. Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Repantis D; Schlattmann P; Laisney O; Heuser I Pharmacol Res; 2010 Sep; 62(3):187-206. PubMed ID: 20416377 [TBL] [Abstract][Full Text] [Related]
15. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure. d'Angelo LC; Savulich G; Sahakian BJ Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges. Ricci G Front Psychiatry; 2020; 11():53. PubMed ID: 32127792 [TBL] [Abstract][Full Text] [Related]
17. Effects of modafinil on cognitive and meta-cognitive performance. Baranski JV; Pigeau R; Dinich P; Jacobs I Hum Psychopharmacol; 2004 Jul; 19(5):323-32. PubMed ID: 15252824 [TBL] [Abstract][Full Text] [Related]
18. Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brain. Urban KR; Gao WJ Front Syst Neurosci; 2014; 8():38. PubMed ID: 24860437 [TBL] [Abstract][Full Text] [Related]
19. Acute Effects of Methylphenidate, Modafinil, and MDMA on Negative Emotion Processing. Schmidt A; Müller F; Dolder PC; Schmid Y; Zanchi D; Egloff L; Liechti ME; Borgwardt S Int J Neuropsychopharmacol; 2018 Apr; 21(4):345-354. PubMed ID: 29206921 [TBL] [Abstract][Full Text] [Related]
20. Impulsivity and attentional bias as predictors of modafinil treatment outcome for retention and drug use in crack-cocaine dependent patients: Results of a randomised controlled trial. Nuijten M; Blanken P; Van den Brink W; Goudriaan AE; Hendriks VM J Psychopharmacol; 2016 Jul; 30(7):616-26. PubMed ID: 27147591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]